Editorial: Refractory GERD-good Drug, Wrong Patients? Authors’ Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Refractory GERD-good Drug, Wrong Patients?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Probiotics in Inflammatory Bowel Disease-Wrong Organisms, Wrong Disease, or Flawed Concepts? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Breaking the Cycle of Cough in GERD-neuromodulators to the Rescue? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Limitations of Defecography Among Patients With Refractory Constipation. Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Editorial: Good News to Patients With Thalassaemia-HCV Clearance Made Easy With Direct Acting Antivirals. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Which Iron Preparation for Patients With IBD? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: The Risk of Cancer in Patients With Gastric Intestinal Metaplasia-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Question-Based Drug Development for Psilocybin – Authors' Reply

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2016English

Letter: Refractory Coeliac Disease and Coeliac-Specific Serology Status - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy